West Tower Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,200
Closed -$382K 53
2025
Q2
$382K Sell
4,200
-300
-7% -$27.4K 0.83% 43
2025
Q1
$422K Sell
4,500
-800
-15% -$71.6K 1.11% 29
2024
Q4
$482K Buy
+5,300
New +$506K 1.07% 23
2023
Q4
Sell
-543
Closed -$38.6K 555
2023
Q3
$38.6K Buy
543
+81
+18% +$6.06K 0.02% 243
2023
Q2
$35.6K Buy
+462
New +$35.8K 0.03% 263

Other funds holding CL

West Tower Group's CL Position: Q3 2025 in Review

West Tower Group sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 4,200 shares — an estimated $382K sold.

West Tower Group first reported a position in CL in Q2 2023 and held it in 5 quarters. The position peaked at $482K in Q4 2024. 1,845 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • West Tower Group reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • West Tower Group sold 4,200 Colgate-Palmolive shares in Q3 2025, an estimated $382K.
  • West Tower Group first reported a position in Colgate-Palmolive in Q2 2023 and held it in 5 quarters.
  • West Tower Group's Colgate-Palmolive position peaked at $482K in Q4 2024.
  • 1,845 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on West Tower Group's 13F filing for Q3 2025, filed 16 Oct 2025.